HAIFA, Israel, Feb. 21, 2013 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the U.S. Food and Drug Administration (FDA) has designated Pluristem’s PLacental eXpanded (PLX) cells orphan drug status…
Tag: catalysts
Synta Pharma: Poised For A Breakout With 4 Near Term Catalysts
Synta Pharmaceuticals Corp. (NASDAQ: SNTA)is a biopharmaceutical company focusing on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. The company has two drug…
Sunday Night Biotech Commentary: $ALXA, $STSI
Some Sunday night biotech commentary, mainly on Jason Napadano’s reference to me on Seeking Alpha (HERE) concerning Alexza (ALXA). I also mention Star Sciences (STSI) as well.
